The clinical use of poly(ethyleneglycol)-coated liposomes (PEG-liposomes) i
s becoming increasingly important. Here we summarize our recent preclinical
and clinical evidence pointing to the possibility of efficient opsonizatio
n of intravenously injected PEG-liposomes under certain circumstances. Dras
tically enhanced blood clearance of PEG-liposomes was observed at low lipid
dose and in case of multiple injection schemes. Further clinical evaluatio
n of the observed ''anti-stealth'' phenomenon is indicated.